• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非重症 COVID-19 患者的呼吸困难感知和神经系统症状。

Dyspnea perception and neurological symptoms in non-severe COVID-19 patients.

机构信息

Respiratory Medicine Unit, University Hospital Policlinico Tor Vergata, Rome, Italy.

Neurology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

出版信息

Neurol Sci. 2020 Oct;41(10):2671-2674. doi: 10.1007/s10072-020-04632-x. Epub 2020 Jul 30.

DOI:10.1007/s10072-020-04632-x
PMID:32734396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7391028/
Abstract

INTRODUCTION

The relationship between dyspnea and COVID-19 is unknown. In COVID-19 patients, the higher prevalence of neurological symptoms and the lack of dyspnea may suggest common underlying pathogenetic mechanisms. The aim of this preliminary study is to address whether there is a lack of dyspnea in COVID-19 patients and if there is a relationship between neurological symptoms and the perception of dyspnea.

METHODS

A structured interview regarding the occurrence of subjective neurological symptoms was performed and coupled with a questionnaire about the intensity and qualities of dyspnea. Respiratory rate (RR) and an arterial blood gas on room air were concurrently evaluated.

RESULTS

Twenty-two patients (age 68.4 ± 13.9 years, 13 males and 9 females) were included and divided into two groups according to the Borg dyspnea scale: dyspneic patients BU ≥ 1(DYSP) and non-dyspneic patients BU < 1 (NDYSP). The prevalence of dyspnea overall was 31.8%. The prevalence of neurological symptoms, dyspnea descriptors, RR, pH, PaCO, PaO, or lactate was similar between groups.

CONCLUSION

This study confirms that the prevalence of dyspnea is low in non-severe COVID-19 patients, but contrary to our hypothesis of a relationship between shortness of breath and neurological symptoms, we have not been able to find any evidence of an impairment in dyspnea perception, either in the DYSP or NDYSP group.

摘要

引言

呼吸困难与 COVID-19 之间的关系尚不清楚。在 COVID-19 患者中,更高的神经系统症状发生率和缺乏呼吸困难可能表明存在共同的潜在发病机制。本初步研究旨在探讨 COVID-19 患者是否存在呼吸困难不足的情况,以及神经系统症状与呼吸困难感知之间是否存在关系。

方法

对主观神经系统症状的发生进行了结构化访谈,并结合了呼吸困难的强度和特征的问卷。同时评估了呼吸频率 (RR) 和在室温下的动脉血气。

结果

共纳入 22 例患者(年龄 68.4±13.9 岁,男性 13 例,女性 9 例),并根据 Borg 呼吸困难量表分为两组:呼吸困难患者 BU≥1(DYSP)和非呼吸困难患者 BU<1(NDYSP)。呼吸困难的总体发生率为 31.8%。两组间的神经系统症状、呼吸困难描述符、RR、pH、PaCO、PaO 或乳酸的发生率相似。

结论

本研究证实,非重症 COVID-19 患者的呼吸困难发生率较低,但与我们关于呼吸困难与神经系统症状之间存在关系的假设相反,我们没有发现任何证据表明在 DYSP 或 NDYSP 组中存在呼吸困难感知受损的情况。

相似文献

1
Dyspnea perception and neurological symptoms in non-severe COVID-19 patients.非重症 COVID-19 患者的呼吸困难感知和神经系统症状。
Neurol Sci. 2020 Oct;41(10):2671-2674. doi: 10.1007/s10072-020-04632-x. Epub 2020 Jul 30.
2
Dyspneic and non-dyspneic (silent) hypoxemia in COVID-19: Possible neurological mechanism.新型冠状病毒肺炎中的呼吸困难型和非呼吸困难型(无症状)低氧血症:可能的神经机制
Clin Neurol Neurosurg. 2020 Nov;198:106217. doi: 10.1016/j.clineuro.2020.106217. Epub 2020 Sep 9.
3
Predictors of Intensive Care Unit admission in patients with coronavirus disease 2019 (COVID-19).2019冠状病毒病(COVID-19)患者入住重症监护病房的预测因素
Monaldi Arch Chest Dis. 2020 Jul 15;90(3). doi: 10.4081/monaldi.2020.1410.
4
Comparison of International Classification of Diseases and Related Health Problems, Tenth Revision Codes With Electronic Medical Records Among Patients With Symptoms of Coronavirus Disease 2019.国际疾病分类与相关健康问题第十版与电子病历在以冠状病毒病 2019 症状就诊患者中的比较。
JAMA Netw Open. 2020 Aug 3;3(8):e2017703. doi: 10.1001/jamanetworkopen.2020.17703.
5
The neurological impact of COVID-19.新型冠状病毒肺炎的神经学影响。
Lancet Neurol. 2020 Jun;19(6):471. doi: 10.1016/S1474-4422(20)30142-3. Epub 2020 May 26.
6
[Chest pain and dyspnea during the recovery period of COVID-19 pneumonia].[新型冠状病毒肺炎恢复期的胸痛和呼吸困难]
Ned Tijdschr Geneeskd. 2020 May 7;164:D5095.
7
Platypnea-orthodeoxia after fibrotic evolution of SARS-CoV-2 interstitial pneumonia. A case report.新型冠状病毒肺炎纤维化演变后的平卧呼吸-直立性低氧血症。一例报告。
Acta Biomed. 2020 Aug 10;91(3):ahead of print. doi: 10.23750/abm.v91i3.10386.
8
Neurological consultations and diagnoses in a large, dedicated COVID-19 university hospital.在一家大型的、专门收治新冠肺炎患者的大学医院进行神经科会诊和诊断。
Arq Neuropsiquiatr. 2020 Aug 3;78(8):494-500. doi: 10.1590/0004-282x20200089.
9
Beyond Fever, Cough and Dyspnea: The Neurology of COVID-19.超越发热、咳嗽和呼吸困难:新型冠状病毒肺炎的神经学表现
J Assoc Physicians India. 2020 Sep;68(9):62-66.
10
Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis.新型冠状病毒 2019-nCoV 感染的临床特征及神经系统表现的系统回顾和荟萃分析。
J Neurol. 2020 Oct;267(10):2777-2789. doi: 10.1007/s00415-020-09974-2. Epub 2020 Jun 11.

引用本文的文献

1
The Effect of Deep Respiration and Prone Position on Common Respiratory Symptoms in Patients with COVID-19: A Randomized Clinical Trial.深呼吸和俯卧位对新型冠状病毒肺炎患者常见呼吸道症状的影响:一项随机临床试验
Iran J Nurs Midwifery Res. 2025 Mar 10;30(2):164-169. doi: 10.4103/ijnmr.ijnmr_34_23. eCollection 2025 Mar-Apr.
2
Clinical Presentation and Outcomes of Hospitalized Patients with Chronic Kidney Disease and COVID-19 Variant Omicron.慢性肾脏病合并新冠病毒奥密克戎变异株住院患者的临床表现及预后
Ther Clin Risk Manag. 2024 May 18;20:275-288. doi: 10.2147/TCRM.S458859. eCollection 2024.
3
Level of Dyspnoea in Patients with COVID-19 in Poland.波兰 COVID-19 患者的呼吸困难程度。
Int J Environ Res Public Health. 2022 Sep 26;19(19):12203. doi: 10.3390/ijerph191912203.
4
Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.COVID-19 患者绝对死亡风险评估:Khorshid COVID 队列(KCC)研究。
BMC Med Res Methodol. 2021 Jul 14;21(1):146. doi: 10.1186/s12874-021-01340-8.
5
Evaluation of dyspnea severity and sleep quality in patients with novel coronavirus.评估新型冠状病毒感染患者呼吸困难严重程度和睡眠质量。
Int J Clin Pract. 2021 Oct;75(10):e14631. doi: 10.1111/ijcp.14631. Epub 2021 Jul 20.
6
Happy hypoxemia, or blunted ventilation?快乐低氧血症,还是迟钝的通气?
Respir Res. 2021 Jan 6;22(1):4. doi: 10.1186/s12931-020-01604-9.

本文引用的文献

1
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection.主观神经系统症状在 SARS-CoV2 感染患者中经常出现。
Brain Behav Immun. 2020 Aug;88:11-16. doi: 10.1016/j.bbi.2020.05.037. Epub 2020 May 19.
2
Lack of dyspnea in patients with Covid-19: another neurological conundrum?新冠病毒肺炎患者无呼吸困难:另一个神经学难题?
Eur J Neurol. 2020 Sep;27(9):e40. doi: 10.1111/ene.14265. Epub 2020 May 12.
3
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.中国武汉住院的 2019 年冠状病毒病患者的神经系统表现。
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.
4
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.新加坡 2019 年新型冠状病毒肺炎患者的流行病学特征和临床病程
JAMA. 2020 Apr 21;323(15):1488-1494. doi: 10.1001/jama.2020.3204.
5
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
6
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
7
Respiratory virus infection up-regulates TRPV1, TRPA1 and ASICS3 receptors on airway cells.呼吸道病毒感染会上调气道细胞上的TRPV1、TRPA1和ASIC3受体。
PLoS One. 2017 Feb 10;12(2):e0171681. doi: 10.1371/journal.pone.0171681. eCollection 2017.
8
Common Mechanisms of Dyspnea in Chronic Interstitial and Obstructive Lung Disorders.慢性间质性和阻塞性肺疾病呼吸困难的常见机制。
Am J Respir Crit Care Med. 2016 Feb 1;193(3):299-309. doi: 10.1164/rccm.201504-0841OC.
9
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.美国胸科学会官方声明:呼吸困难机制、评估和管理的更新。
Am J Respir Crit Care Med. 2012 Feb 15;185(4):435-52. doi: 10.1164/rccm.201111-2042ST.
10
Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma.有濒死性哮喘病史患者的化学敏感性和呼吸困难感知
N Engl J Med. 1994 May 12;330(19):1329-34. doi: 10.1056/NEJM199405123301901.